Chinese officials this week visited a regional office of Sanofi, the French pharmaceutical company, in the latest expansion of probes of western drugmakers.
Chris Viehbacher, chief executive, said the ministry of industry and commerce had come to Sanofi’s office in Shenyang, but the reason for the visit was not yet clear.
His comments came as Sanofi posted second-quarter results below expectations despite strong sales in China and cut guidance for 2013 to a 7-10 per cent decline on 2012’s business earnings of €6.14 a share.
您已阅读24%（527字），剩余76%（1637字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。